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ABSTRACT   
The utilization of Smartwatch as a wearable sensor is one of the emergings of E-health development. It is 
easier to carry anywhere becomes one of the supporting factors. However, it is essential to examine the 
reliability and validity of smartwatches in measuring Heart Rate and Blood Pressure associated with medical 
uses. Methods: Eighty-eight healthy participants are recruited to be measured heart rate and Blood Pressure. 
The reliability and validity were determined by comparing the smartwatches with the home standard Blood 
Pressure using mean differences, Bland Altman plot, Interclass correlation coefficient (ICC), and Cronbach's 
alpha. Results: the reliability varied based on the ICC, ranging from 0.533 to 0.852. Two smartwatches 
showed relatively weak ICC and broad limits of agreement of the Bland–Altman plots at both heart rate and 
Blood Pressure Measurement. F1 Smartband Bracelet Watch showed slightly better results for heart rate 
measurement than Y2 Plus Smart Wrist Band. 
Conversely, Y2 Plus Smart Wrist Band demonstrated the best accuracy at Systolic measurement. And for 
Diastolic Blood Pressure was relatively the same in reliability and validity. Conclusion: The reliability and 
validity of smartwatches use, especially for healthcare, are still less accurate for the clinical standard because 
the ICC was lower than <0.9. but for everyday use, it is good reliability and validity. For future work, the 
accuracy of sensor reading of smartwatches needs to improve to reach the clinical standard. 
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Nowadays, People feel more comfortable fulfilling their needs, finish their job, and do all activities using the 
internet. In addition, to fulfill daily needs, the development of the internet is also reaching out to the modern 
health sector; one of these is the development of E-health [1]. E-health helps people check their health and 
consult with their doctors remotely by integrating mobile technology to solve health problems (such as obesity 
and heart disease) and improve consumers' quality of life. One part of E-health is sensors to detect body 
conditions. In 2018, 431 wearable devices place on the wrist, arm, and chest developed based on the wearable 
database[2]. Wearable technology can measure some health parameters, such as Blood Pressure, Oxygen Level 
in Blood (SPO2), Heart Rate, Temperature, And Respiratory Rate. Smartwatch As wearable technology which 
is included in the E-health system to improve the quality of health services. This development makes it possible 
to provide people with information of sensing early symptoms of the disease or precaution of a diseased and 
keep track of the patient's condition [3]. This technology is used to detect the condition of the human body; it 
needs to be validated to minimize measurement errors. Analysis of reliability and validity by comparing several 
smartwatches that support E-health technology needs to be done to determine which Smartwatch is the most 
accurate to use. 
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2. Methods 
2.1. Research method 
Quantitative research is appropriate for describing phenomena by collecting numerical data analyzed utilizing 
mathematically based approaches to conclude [4]. This method is suitable for answering relationships within 
measurable variables to explain, predict and control phenomena [5]. Because this research aimed to calculate 
and analyze the validity and reliability of the smartwatch's measurement results, a quantitative approach was 
the most suitable to analyze data. The prior research about validity and reliability using the quantitative approach 
to produce a complete analysis data consist of a calculation table and graph [6]. 
 
2.2. Participant 
The number of samples drawn is 88 samples (18-65 years) from students, men, and women who studied 
medicine at Management and Science University. All participants had to choose based on inclusion and 
exclusion criteria to key out the information relevant in answering the research question [7]. The eligible 
participant will be informed about the test procedure and sign a consent form before doing data collection based 
on the inclusion and exclusion criteria. 
 
2.3. Instrumentation 
Several instruments were used in this research: Y2 Plus Smart Wrist Band, F1 Smart band Bracelet Watch, and 
Omron HEM-7322 used as Home Standard Device. Y2 Plus Smart Wrist Band will be labeled as Smartwatch 
A, and F1 Smart band Bracelet Watch will be marked as Smartwatch B. 
This study used an experimental method to obtain participant's data on heart rate and blood pressure. This 
research will be held in a testing laboratory, which means that participants will be observed by a medical student 
who joins as a committee for the MIG-WHEALTH Conference. The data using smartwatches will be collected 
with Omron Digital Blood Pressure in both blood pressure. Before collecting data on heart rate and Blood 
Pressure, the participant was asked about demographic information, for example, age, gender, height, weight, 
and sign the consent form. Height and Weight information got it from direct measurement before doing blood 
pressure measurement. Data collection will do simultaneously between the Omron Blood Pressure, Y2 Plus 
Smart Wrist Band, and F1 Smart band Bracelet Watch. 
 
2.4. Statistical analysis 
The data collection was collected completely to do statistical analysis. IBM SPSS Statistics 24 and Microsoft 
Excel are used as software for doing statistical analysis. After removing ineligible data, the filtered data will be 
imputed into IBM SPSS Statistic 24 software. Descriptive analysis corresponded to identifying the 
characteristics of an observed phenomenon or exploring correlations between two or more entities. The variable 
such as height, weight, gender, BMI, mean heart rate, mean systolic Blood Pressure, and diastolic Blood 
Pressure will be assessed. 
This research will use the two types of inferential statistics: agreement and correlation, to assess validity and 
reliability. There are several correlation tests based on three distinct categories, nominal, ordinal, and interval. 
If the normality test showed the normal distribution, the parametric test could be used as correlation analysis. 
Pearson correlation will assess to obtain the correlation level and the significance measurement. P-value against 
a prespecified level of significance, which is often chosen to be 0.05. If P-value <0.05, the measurement cannot 
accept as highly significant, or vice versa. The Scatter Plot will assess the relationship between two variables to 
make it easy to understand whether the data was a positive or negative correlation. Through the calculation 
result and correlation graph, it can be used to measure the validity of smartwatches. 
Intraclass correlation coefficient (ICC) is a widely used reliability index; in other words, it reflects the degree 
of correlation and the agreement between measurements. With values closer to 1 representing more substantial 
reliability. A two-way random-effect model based on single ratings and a whole deal will be assessed. Default 
95% Confidence Intervals (CI) will be used for each ICC based on the prior studies [8]. The Bland and Altman 
(BA) Plot were used to assess the level of agreement between smartwatches and Omron Blood Pressure. 
Calculation of mean difference and limit of agreement (upper and lower) will be evaluated, and place in the 
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scatter plot. The reliability of the two smartwatches will be analyzed using Cronbach Alpha Coefficient [9]. The 
Cronbach Alpha coefficient and ICC rating scale was used to determine the reliability, as shown in Table 1.  
Table 1. Rating Scale Instrument Quality Criteria [10] 
 
Item Measurement Reliability and Correlation 
above 0.94 Excellent 





3. Results  
3.1. Demographic characteristic 
The results showed 37.46% (33) are Male participants and 62.54% (55) are Female participants. All participants 
are medical students of Management and Science University that join the conference event. Most participants 
were normal weight, about 58.31%, 30.14% for overweight participants, and 11.56% for underweight 
participants. This research classified the aged range into three categories, <18 years, 19-25 years, and >25 years. 
The mean and standard deviation of age distribution was 24.66 years with standard deviation (SD=3.62). 
68.66% of participants are aged between 19 and 25 years, and 31.34% for more than 25 years. The mean and 
standard deviation of body mass index was 23 kg/m2 (SD = 4.049). The mean result of weight and height, 
respectively were 58.41 kg (SD = 11.099), 158.52 cm (SD = 7.925)). 
The mean Heart Rate for all eligible data was 87 Bpm (SD=9.18) for Omron Blood Pressure, 81 Bpm (SD=8.18) 
for mean Heart Rate used Smartwatch A and 87 Bpm (SD=8.77) for mean Heart rate assessed using Smartwatch 
B. The mean Systolic Blood Pressure was 116.53 mmHg (SD=12.575) for Omron Blood Pressure, 118.02 
mmHg (SD=9.753) for Blood Pressure using Smartwatch A and 120.30 mmHg (SD=11.842) for Blood Pressure 
assessed using Smartwatch B. The mean Diastolic Blood Pressure was 77.48 mmHg (SD=7.662), 79.03 mmHg 
(SD=6.675), and 79.36 mmHg (SD=6.952) for Omron Digital Blood Pressure, Smartwatch A, and Smartwatch 
B. 
 
3.2. Preliminary statistical analyses 
Normality test was assessed before doing another statistical analysis. This test is essential to determine the 
following statistical analysis to obtain excellent and valid data. Based on the trial using Shapiro Wilk Test, the 
result shown that data are normally distributed. 
3.3. Pearson correlation test 
A correlation test was used to know the relationship between two variable scores. The Pearson Correlation 
Coefficient result in Heart Rate compare with Omron BP for Smartwatch A r=0.472; P<0.001 and r=0.593; 
P<0.001 for smartwatch B. Then, from the Pearson correlation result, smartwatch A/B and Omron BP show a 
significant result as P-value 0.001<0.05, which means a significant correlation between the two devices. Pearson 
Correlation Coefficient result in Systolic Blood Pressure A was r=0.763; P<0.001, and smartwatch B was 
r=0.654; P<0.001. P-value calculation of smartwatch A and smartwatch B with Omron BP show a significant 
result as P-value 0.001<0.05. The Pearson Correlation Coefficient result between smartwatches and Omron BP 
was r=0.595; P<0.001 for smartwatch A and r=0.551; P<0.001 for smartwatch B. 
3.4. Intraclass correlation coefficient (ICC) 
The intraclass correlation coefficient (ICC) is a widely used reliability index in reliability analyses[11]. This 
research used ICC(2,1) with a two-way random effect, with the absolute agreement and single 
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rater/measurement. The average ICC of smartwatch A is 0.564 with 95% confidence interval from 0.222 to 
0.743 (F(87)= 2.769, p<.001. The average ICC of Smartwatch B compare with Omron Blood Pressure was 
0.745 with a 95% confidence interval from 0.611to 0.833 (F(87)= 3.89, p<.001). The average ICC of 
Smartwatch A compare with Omron Blood Pressure in systolic measurement was 0.852 with a 95% confidence 
interval from 0.774 to 0.903 (F(87)= 6.77, p<.001). The average ICC of Smartwatch B compare with Omron 
Blood Pressure in systolic measurement was 0.771 with a 95% confidence interval from 0.631 to 0.855 (F(87)= 
4.757, p<.001). The average ICC of Smartwatch A compare with Omron Blood Pressure in diastolic 
measurement was 0.733 with a 95% confidence interval from 0.592 to 0.826 (F(87)= 3.875, p<.001). 
 
3.5. Level of agreement 
Correlation quantifies the degree to which two variables are related. A high correlation does not automatically 
imply a good agreement between the two methods [11]. The result shows that the mean difference reaches 5.53 
Bpm with limits of agreement in heart rate measurement: lower limit = −12.10 Bpm to upper limit= 23.17 Bpm. 
Then, the mean difference was -1.01 mmHg and limits of agreement −16.63 mmHg to 14.61 mmHg for Systolic 
Blood Pressure. The Bland Altman for Diastolic shows the same result; the mean difference was -1.54; the 
limits of agreement were again too wide (−14.30 mmHg to 11.21 mmHg) for the level of agreement based on 




Figure 1. Bland Altman plot for Heart Rate Blood 
Pressure Omron Blood Pressure and Smartwatch A 
 
 
Figure 2. Bland Altman plot for Systolic Blood 





Figure 3. Bland Altman plot for Diastolic Blood 
Pressure Omron Blood Pressure and Smartwatch A 
 
Figure 4. Bland Altman plot for Heart Rate Omron 
Blood Pressure and Smartwatch B 




Figure 5. Bland Altman plot for Systolic Blood 
Pressure Omron Blood Pressure and Smartwatch B 
 
 
Figure 6. Bland Altman plot for Diastolic Blood 
Pressure Omron Blood Pressure and Smartwatch B 
 
The result shows that the mean difference reaches -0.32 Bpm with limits of agreement in heart rate 
measurement: upper limit = 15.54.10 Bpm to lower limit= -16.19 Bpm. Then, the mean difference was -3.57 
mmHg and limits of agreement −23.07 to 15.91 mmHg for Systolic Blood Pressure. The Bland Altman for 
Diastolic shows the same result; the mean difference was -1.88 the limits of agreement were again too wide 
(−15.51 to 11.74 mmHg) for the level of agreement based on comparison Blood Pressure range of within 10 
mmHg and 20 mmHg for Diastolic [12]. The limit of the agreement was too wide for each variable, heart rate, 
systolic and diastolic.  
3.6. Reliability analysis.  
One of the critical issues of reliability concerns the scale's consistency. One of the most commonly used 
indicators of internal consistency is Cronbach's alpha coefficient (α). To obtain Cronbach's alpha, the calculation 
using formula (1) was used. The comparison result of Reliability between Smartwatch A and Smartwatch B is 
shown in Table 2. 
 
 
𝛼 =  
𝑘 𝑋 𝑐 ̅
?̅?+ (𝑘−1)𝑐
 ̅                (1) 
 
Where 𝛼= Cronbach alpha 
 k = the number of scale items 
      𝑐̅ =the average of all covariances between items 
      ?̅? = the average variance of each item 
Table 2. Reliability between smartwatch A and B with Omron Blood Pressure, using Cronbach Alpha 
Blood Pressure Method of Comparison Cronbach Alpha 
Systolic Blood Pressure 
Smartwatch A and Omron BP 0.852 
Smartwatch B and Omron BP 0.790 
Diastolic Blood Pressure 
Smartwatch A and Omron BP 0.742 
Smartwatch B and Omron BP 0.708 
Heart Rate 
Smartwatch A and Omron BP 0.639 
Smartwatch B and Omron BP 0.744 
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Using equation (1), the calculation of Cronbach's alpha has done for all variables, heart rate, systolic, and 
diastolic blood pressure. The calculation result was shown in Table 2; the Smartwatch A shows the Cronbach 
Alpha reliability reach α =0.852 for Systolic Blood Pressure and α =0.742 for Diastolic Blood Pressure. Heart 
rate 𝛼 have a weak to fair reliability with 𝛼 = 0.639. The smartwatch B showed the Cronbach Alpha reliability 
reach 0.790 for Systolic Blood Pressure and 0.708 for Diastolic Blood Pressure. 
 
4. Discussion 
4.1. Reliability of smartwatch measurement 
The reliability of the smartwatch measurement was assessed using the Cronbach Alpha coefficient. As described 
in Table 2, systolic Blood Pressure has the highest degree of reliability(α=0.852), and heart rate measurement 
has the lowest degree of reliability (=α 0.639). The reliability of diastolic measurement in both smartwatch A 
and smartwatch B were relatively same. For statistical analysis, it is quite good if the reliability more than 0.6 
[9]. It could be concluded based on statistical analysis of reliability using Cronbach Alpha. The results show 
pretty satisfactory results; however, for healthcare, the level of reliability still needs to be increased. 
Nevertheless, the current work still less than the clinical standard. The alpha number should at least be 0.90, 
and then the Smartwatch can be stated as a valid device for healthcare use. 
 
4.2. Validity of smartwatch measurement 
There are several ways to assess the validity of smartwatches in laboratory conditions. Based on [6], there are 
three methods for determining the validity, assess systematic difference, examine Interclass Correlation 
Coefficient (ICC), and assess the level of agreement. This research used two of three methods to investigate the 
Interclass Correlation Coefficient (ICC) and the level of agreement to assess the level of validity.   
The use of correlation coefficients is the most common method of analyzing this type of medical result. Pearson 
correlation coefficient result of smartwatch A and Omron Blood Pressure showed a weak correlation in heart 
rate measurement. The Pearson correlation coefficient result for heart rate is still lower than 0.6. 
The Pearson correlation was r=472; P<0.001 and smartwatch B r=593; P<0.001. Diastolic Blood Pressure 
measurement also has a weak Pearson correlation in two smartwatches measurements, but smartwatch A was 
slightly better than smartwatch B.  For the Systolic Blood Pressure, smartwatch A tends to have a reasonable 
correlation, assessed using Pearson correlation coefficient or Interclass correlation coefficient. The result was 
r=0.763, P < 0.001 for comparison of systolic blood pressure Smartwatch A and Omron Blood Pressure and 
r=0.654, P<0.001 for comparison systolic blood pressure, smartwatch B and Omron Blood Pressure. The result 
was r=0.595, P < 0.001 for comparison of systolic blood pressure Smartwatch A and Omron Blood Pressure 
and r=0.551, P<0.001 for comparison systolic blood pressure, smartwatch B and Omron Blood Pressure. 
ICC result of smartwatch A and B showed that smartwatch B was better than A, resulting from ICC smartwatch 
B 0.745 with P<0.001 in heart rate measurement. Despite the lower ICC of smartwatch A, the P-value of 
Smartwatch A is also significant (P<0.001).ICC result of smartwatch A and B showed that smartwatch A was 
better than B, Smartwatch A ICC=0.852 with P<0.001 in systolic measurement and diastolic measurement 
ICC=0.733 with P<0.001. 
The other analysis was used to convince the validity degree. The level of agreement of Bland Altman plots is 
used to assess the difference between lower and upper limits of agreement [6]. Some research has given the 
wide limits of agreement that neither is sufficient to predict ambulatory Blood Pressure [13]. The significant 
finding was considerable variability between the two types of Blood Pressure measurements, with wide limits 
of agreement for Systolic and Diastolic Blood Pressure. 
It shows in Figure 2, the mean difference for Smartwatch A compares with Omron Blood Pressure was -1.01 
mmHg, but the limits of agreement are still wide, −16.63 mmHg to 14.61 mmHg for Systolic Blood Pressure. 
The same result is shown in Figure 5. The agreement between Omron Blood Pressure and Smartwatch B, the 
mean difference was -3.57 mmHg higher than Smartwatch A, with limits of agreement of −23.07 mmHg to 
15.91 mmHg for Systolic Blood Pressure. The level of agreement was assessed between smartwatches, and 
Omron Blood Pressure showed a wide range in heart rate; both smartwatch A and smartwatch B calculated more 
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than 30 Blood Pressure for individual measurement. It is the same with the analysis of the previous research in 
heart rate measurement using Fitbit charge 2 [14]. Blood Pressure measurement also gets a wide limit of 
agreement, as the standard set 10 mmHg difference for diastolic and 20 mmHg for Systolic Blood Pressure [15]. 
The validity heart rate measurement of the two smartwatches is weak, but the validity is good for Blood 
Pressure. However, the clinical validity cannot accept the measurement result. The statistical analysis showed 
below the clinical standard indicated in the Bland Altman Plot, as shown in Figure 1-6. As stated by [14], one 
aspect that makes the wide range limit of agreement was indicated the un proper placement of device would 
affect the measurement result. 
5. Conclusion and future work 
A prominent accuracy level is needed for E-health usage. This research shows that Pearson's correlations 
between Smartwatch A or Smartwatch B with Omron Blood Pressure measurements were high. Still, it is 
inadequate when measuring heart rate, the Pearson Correlation Coefficient can reach. In the same way, the 
reliability of Smartwatch Assesses using Cronbach's Alpha coefficient, and the result shows good reliability as 
showed that calculation was between 0.6-0.8. the best Smartwatch between two devices for heart rate 
measurement was smartwatch B, and even the statistical result showed a slightly better number. And for blood 
pressure validity and reliability, this research concludes that the best was Smartwatch A. But, for clinical 
purposes or healthcare, two smartwatches were still less accurate as the standard for validity and reliability were 
must be more than 0.9. In future work, examine the Blood Pressure and Heart Rate of other wearable devices in 
different physical activities, comparing to the Gold Standard Devices in Hospital, is needed. Then, we can know 
physical activities can impact the reliability and validity of wearable devices for E-Health. 
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